Sankyo Drug Patent Portfolio

Sankyo owns 1 orange book drug protected by 4 US patents Given below is the list of Sankyo's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5859037 Sulfonylurea-glitazone combinations for diabetes 13 Nov, 2017 Expired
US6011049 Combinations for diabetes 13 Nov, 2017 Expired
US5602133 Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus 15 Sep, 2013 Expired
US6046202 Use of thiazolidinedione derivatives in the treatment of insulin resistance 15 Sep, 2013 Expired


Sankyo's Family Patents


Family Patents



Sankyo Drug List

Given below is the complete list of Sankyo's drugs and the patents protecting them.


1. Prelay

Prelay is protected by 4 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5859037 Sulfonylurea-glitazone combinations for diabetes 13 Nov, 2017
(6 years ago)
Expired
US6011049 Combinations for diabetes 13 Nov, 2017
(6 years ago)
Expired
US5602133 Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus 15 Sep, 2013
(11 years ago)
Expired
US6046202 Use of thiazolidinedione derivatives in the treatment of insulin resistance 15 Sep, 2013
(11 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Prelay's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Sankyo News

Enhertu poised for success as it surpasses Kadcyla in performance, predicts Yahoo Finance.

22 Jul, 2024

See More